[A13-18] Addendum to Commission A12-18 (dapagliflozin)
|Commission:||Commission awarded on 2013-04-23 by the Federal Joint Committee (G-BA)|
|Current document:||Addendum to Commission A12-18 (dapagliflozin) Further documents|
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
|Contact address:||to the contact form|
Dapagliflozin - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Status: Commission completed
|2013-06-06||Addendum to Commission A12-18 (dapagliflozin)||234 kB|
Federal Joint Committee (G-BA)
2013-06-06 A G-BA decision was published.